Pfizer Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Patient Information Leaflet last updated on the eMC: 15/07/2010
PIL Epanutin Infatabs

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 15/07/2010 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to drug interactions
  • Change to MA holder contact details
Updated on 02/06/2010 and displayed until 15/07/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 28/01/2009 and displayed until 02/06/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 20/01/2009 and displayed until 28/01/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change due to user-testing of patient information
Updated on 24/12/2008 and displayed until 20/01/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 20/12/2005 and displayed until 24/12/2008
Reasons for adding or updating:
  • No reasons supplied
Updated on 30/03/2005 and displayed until 20/12/2005
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 23/03/2005 and displayed until 30/03/2005
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 23/03/2004 and displayed until 23/03/2005
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   phenytoin